12,258
edits
If you're interested in becoming a contributor or requesting changes then click here to join the discord
Changes
Jump to navigation
Jump to search
Axonics Modulation Technologies (view source)
Revision as of 21:32, 22 February 2022
, 21:32, 22 February 2022no edit summary
Line 2:
Line 2:
[[Category:Companies]]
[[Category:Companies]]
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
+
+
+[[File:Axonics_Modulation_Technologies.png|thumb|Axonics Modulation Technologies Company Profile]]
+Founded in The United States around 2012, Axonics Modulation Technologies produces invasive hardware.
+
+Axonics Modulation Technologies makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
+
+[[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent
==Links==
==Links==
[http://axonicsmodulation.com Website]
[http://axonicsmodulation.com Website]
[https://www.crunchbase.com/organization/axonics-modulation-technologies Crunchbase]
[https://www.crunchbase.com/organization/axonics-modulation-technologies Crunchbase]
[https://www.linkedin.com/company/axonics/ LinkedIn]
[https://www.linkedin.com/company/axonics/ LinkedIn]